Suchergebnisse

Monica Berner - Senior Vice President, Chief Clinical Officer and Markets Shared Services - hält ein degree in Medicine der Baylor College of Medicine.

Dennis Pullin - Director - hält ein Certificate in Post-Graduate Studies & Cardiac Rehabilitation der Baylor College of Medicine.

Brad Hoyt - Chief Medical Information Officer - has a Doctor of Medicine from Baylor College of Medicine and Bachelor from Rice University.

Ruxandra Draghia-akli - Global Head, Global Public Health - has a Doctoral Fellow in Molecular Biology and Gene Therapy from Baylor College of Medicine and PhD in Genetics & Gene Therapy from Paris Cité University.

Phuong Khanh - Head, Therapeutic Area Unit - hält ein Internal Medicine Residency Program der Baylor College of Medicine.

Sean Martin - Chief Medical Officer - has a Doctor of Medicine from Baylor College of Medicine and Bachelor of Arts in Human Biology from Stanford University.

Bryan Leibman - President and Chief Executive Officer - has a Doctor of Medicine from Baylor College of Medicine and Bachelor of Arts from University of Maryland.

Dennis Pullin - Director - hält ein Certificate in Post-Graduate Studies & Cardiac Rehabilitation der Baylor College of Medicine.

Juan Vera - President & Managing Director, Iberia - hält ein Postdoctoral Fellow in Center for Cell and Gene Therapy der Baylor College of Medicine.

Chris Mirabelli - Chairman of the Board - has a PhD from Baylor College of Medicine and Bachelor from State University of New York at Fredonia.

Henry Skinner - Director - has a PostDoc Human and Molecular Genetics from Baylor College of Medicine and PhD in Microbiology from University of Illinois.

Mo Qatanani - Chief Scientific Officer - has a PhD in Molecular and Human Genetics from Baylor College of Medicine and Master of Science in Biochemistry from American University of Beirut.

Phuong Khanh - Director - hält ein Internal Medicine Residency Program der Baylor College of Medicine.

Henry Skinner - Director - has a PostDoc Human and Molecular Genetics from Baylor College of Medicine and PhD in Microbiology from University of Illinois.

Daniel Vlock - Chief Medical Officer - has a Doctor of Medicine from Baylor College of Medicine and ba In English Literature from Cornell University.

Frank Bennett - Executive Vice President and Chief Scientific Officer - has a PhD in Pharmacology from Baylor College of Medicine and Bachelor of Science In Pharmacy from University of New Mexico.

Martin Huber - Director, President and Chief Executive Officer - hält ein Doctor of Medicine der Baylor College of Medicine.

Ruxandra Draghia-Akli - Executive Vice President and Head of Research & Development - has a Doctoral Fellow in Molecular Biology and Gene Therapy from Baylor College of Medicine and PhD in Genetics & Gene Therapy from Paris Cité University.

Regis Vilchez - Chief Medical Officer - hält ein PhD in Clinical Investigation and Virology der Baylor College of Medicine.

Richard Buller - Director - has a PhD Cell Biology from Baylor College of Medicine and Medical Doctorate from Baylor College of Medicine.

Jonathan Pachter - Chief Scientific Officer - has a Phd in Neuroscience from Baylor College of Medicine and Postdoc Pharmacology from Yale University - School of Medicine.

James Lu - Director, President and Chief Executive Officer - has a PhD in Machine Learning, Genomics, Neuroscience and Medicine from Baylor College of Medicine and Master of Science in Chemical Engineering from Stanford University.

Henry Skinner - Director - has a PostDoc Human and Molecular Genetics from Baylor College of Medicine and PhD in Microbiology from University of Illinois.

Chris Mirabelli - Chairman of the Board - has a PhD from Baylor College of Medicine and Bachelor from State University of New York at Fredonia.

Martin Huber - Director - hält ein Doctor of Medicine der Baylor College of Medicine.

Juan Vera - Chief Executive Officer - hält ein Postdoctoral Fellow in Center for Cell and Gene Therapy der Baylor College of Medicine.